Archives: Document Center
Enroll-HD
GC Dose Reduction with CRENESSITY™ (Crinecerfont) In Adults
GC Dose Reduction with CRENESSITY™ (Crinecerfont) In Pediatric Patients
GC Stress Dosing Procedure in the Phase 3 CAHtalyst™ Pediatric Study
GC Stress Dosing Procedure in the Phase 3 CAHtalyst™ Study
Use of INGREZZA® (valbenazine) Capsules and INGREZZA® SPRINKLE
Understanding Huntington’s Disease Chorea: Functional Impact and Best Practices (17:04)
Two movement disorder neurologists, Dr. Lauren Seeberger and Dr. Victor Sung, describe how Huntington’s disease chorea has significantly disrupted the everyday lives of their patients. They provide real-life examples of the functional impact of chorea at work and home, suggest specific questions to ask and areas to focus on to assess impact, and describe the […]